In last trading session, Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) saw 0.3 million shares changing hands with its beta currently measuring 1.54. Company’s recent per share price level of $1.18 trading at -$0.06 or -4.84% at ring of the bell on the day assigns it a market valuation of $0.28M. That closing price of BDRX’s stock is at a discount of -1662.71% from its 52-week high price of $20.80 and is indicating a premium of 43.22% from its 52-week low price of $0.67. Taking a look at company’s average trading volume volume of 3.36 million if we extend that period to 3-months.

Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) trade information

Upright in the red during last session for losing -4.84%, in the last five days BDRX remained trading in the red while hitting it’s week-highest on Tuesday, 04/30/24 when the stock touched $1.18 price level, adding 26.71% to its value on the day. Biodexa Pharmaceuticals Plc ADR’s shares saw a change of -55.97% in year-to-date performance and have moved -9.23% in past 5-day. Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) showed a performance of 1.72% in past 30-days.

1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 240k for the same. And 1 analysts are in estimates of company making revenue of 370k in the next quarter.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 86.34% during past 5 years.

BDRX Dividends

Biodexa Pharmaceuticals Plc ADR is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.